A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The index has shown a price gain of 305.13% this year. Over the last six months, there has been a stronger performance of -34.49%. The price of CRVO fallen by 334.86% during the last 30 days period. For the last 5-days stocks have slided -33.66%.
CervoMed Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $25.92 on 04/15/24, while the lowest value for the same period was recorded at $1.80 on 12/17/24.
52-week price history of CRVO Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. CervoMed Inc’s current trading price is -63.43% away from its 52-week high, while its distance from the 52-week low is 426.67%. The stock’s price range during this period has varied between$1.80 and $25.92. The CervoMed Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.05 million for the day, a figure considerably lower than their average daily volume of 4.68 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
CervoMed Inc (CRVO) has experienced a quarterly rise of 327.03% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 82.50M and boasts a workforce of 15 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.32, with a change in price of -4.17. Similarly, CervoMed Inc recorded 3,050,990 in trading volume during the last 100 days, posting a change of -30.55%.
CRVO’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CRVO stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
CRVO Stock Stochastic Average
As of today, CervoMed Inc’s raw stochastic average for the last 50 days stands at 50.33%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 50.33%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 44.23% and 44.93%, respectively.
